Cargando…

Combined Treatment With Hyperbaric Oxygen Therapy and Endovascular Therapy for Patients With Chronic Limb-Threatening Ischemia ― Study Protocol for the HOTFOOT Multicenter Randomized Controlled Trial ―

Background: Hyperbaric oxygen therapy (HBOT) is regarded as one of the therapeutic options added to standard care to improve lower-limb outcomes in patients with chronic limb-threatening ischemia (CLTI). However, the current guidelines specify that HBOT should not be offered instead of revasculariza...

Descripción completa

Detalles Bibliográficos
Autores principales: Sato, Yusuke, Urasawa, Kazushi, Morishita, Tetsuji, Tan, Michinao, Hayakawa, Naoki, Tokuda, Takahiro, Nakano, Akira, Miyazawa, Tsuyoshi, Shimooka, Yoshinori, Minegishi, Yoshiki, Dannoura, Yutaka, Ikeda, Hiroyuki, Hayashi, Taichi, Miwa, Takashi, Hieda, Shohei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Circulation Society 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8651475/
https://www.ncbi.nlm.nih.gov/pubmed/34950800
http://dx.doi.org/10.1253/circrep.CR-21-0097
_version_ 1784611404411568128
author Sato, Yusuke
Urasawa, Kazushi
Morishita, Tetsuji
Tan, Michinao
Hayakawa, Naoki
Tokuda, Takahiro
Nakano, Akira
Miyazawa, Tsuyoshi
Shimooka, Yoshinori
Minegishi, Yoshiki
Dannoura, Yutaka
Ikeda, Hiroyuki
Hayashi, Taichi
Miwa, Takashi
Hieda, Shohei
author_facet Sato, Yusuke
Urasawa, Kazushi
Morishita, Tetsuji
Tan, Michinao
Hayakawa, Naoki
Tokuda, Takahiro
Nakano, Akira
Miyazawa, Tsuyoshi
Shimooka, Yoshinori
Minegishi, Yoshiki
Dannoura, Yutaka
Ikeda, Hiroyuki
Hayashi, Taichi
Miwa, Takashi
Hieda, Shohei
author_sort Sato, Yusuke
collection PubMed
description Background: Hyperbaric oxygen therapy (HBOT) is regarded as one of the therapeutic options added to standard care to improve lower-limb outcomes in patients with chronic limb-threatening ischemia (CLTI). However, the current guidelines specify that HBOT should not be offered instead of revascularization to prevent limb loss in CLTI patients. The aim of the HOTFOOT study is to examine the impact of HBOT on wound healing in CLTI patients after successful endovascular therapy (EVT). Methods and Results: The HOTFOOT study is a multicenter prospective randomized open blinded-endpoint trial that is to be conducted at 10 trial centers in Japan between February 2021 and February 2022. This study will enroll 140 patients with CLTI receiving successful EVT. Eligible participants will be allocated 1 : 1 to either the EVT+HBOT or EVT group; participants in the EVT+HBOT group will receive 30 HBOT sessions. The primary outcome is the time to complete wound healing over the 6-month follow-up. Secondary outcomes during the 6-month follow-up are the proportion of patients who achieved complete wound healing, freedom from major lower-limb amputation, amputation-free survival, and freedom from target lesion reintervention. Conclusions: This study is expects to assess whether HBOT, in combination with successful EVT, can improve lower-limb outcomes in CLTI patients.
format Online
Article
Text
id pubmed-8651475
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher The Japanese Circulation Society
record_format MEDLINE/PubMed
spelling pubmed-86514752021-12-22 Combined Treatment With Hyperbaric Oxygen Therapy and Endovascular Therapy for Patients With Chronic Limb-Threatening Ischemia ― Study Protocol for the HOTFOOT Multicenter Randomized Controlled Trial ― Sato, Yusuke Urasawa, Kazushi Morishita, Tetsuji Tan, Michinao Hayakawa, Naoki Tokuda, Takahiro Nakano, Akira Miyazawa, Tsuyoshi Shimooka, Yoshinori Minegishi, Yoshiki Dannoura, Yutaka Ikeda, Hiroyuki Hayashi, Taichi Miwa, Takashi Hieda, Shohei Circ Rep Protocol Paper Background: Hyperbaric oxygen therapy (HBOT) is regarded as one of the therapeutic options added to standard care to improve lower-limb outcomes in patients with chronic limb-threatening ischemia (CLTI). However, the current guidelines specify that HBOT should not be offered instead of revascularization to prevent limb loss in CLTI patients. The aim of the HOTFOOT study is to examine the impact of HBOT on wound healing in CLTI patients after successful endovascular therapy (EVT). Methods and Results: The HOTFOOT study is a multicenter prospective randomized open blinded-endpoint trial that is to be conducted at 10 trial centers in Japan between February 2021 and February 2022. This study will enroll 140 patients with CLTI receiving successful EVT. Eligible participants will be allocated 1 : 1 to either the EVT+HBOT or EVT group; participants in the EVT+HBOT group will receive 30 HBOT sessions. The primary outcome is the time to complete wound healing over the 6-month follow-up. Secondary outcomes during the 6-month follow-up are the proportion of patients who achieved complete wound healing, freedom from major lower-limb amputation, amputation-free survival, and freedom from target lesion reintervention. Conclusions: This study is expects to assess whether HBOT, in combination with successful EVT, can improve lower-limb outcomes in CLTI patients. The Japanese Circulation Society 2021-10-20 /pmc/articles/PMC8651475/ /pubmed/34950800 http://dx.doi.org/10.1253/circrep.CR-21-0097 Text en Copyright © 2021, THE JAPANESE CIRCULATION SOCIETY https://creativecommons.org/licenses/by-nc-nd/4.0/This article is licensed under a Creative Commons [Attribution-NonCommercial-NoDerivatives 4.0 International] license.
spellingShingle Protocol Paper
Sato, Yusuke
Urasawa, Kazushi
Morishita, Tetsuji
Tan, Michinao
Hayakawa, Naoki
Tokuda, Takahiro
Nakano, Akira
Miyazawa, Tsuyoshi
Shimooka, Yoshinori
Minegishi, Yoshiki
Dannoura, Yutaka
Ikeda, Hiroyuki
Hayashi, Taichi
Miwa, Takashi
Hieda, Shohei
Combined Treatment With Hyperbaric Oxygen Therapy and Endovascular Therapy for Patients With Chronic Limb-Threatening Ischemia ― Study Protocol for the HOTFOOT Multicenter Randomized Controlled Trial ―
title Combined Treatment With Hyperbaric Oxygen Therapy and Endovascular Therapy for Patients With Chronic Limb-Threatening Ischemia ― Study Protocol for the HOTFOOT Multicenter Randomized Controlled Trial ―
title_full Combined Treatment With Hyperbaric Oxygen Therapy and Endovascular Therapy for Patients With Chronic Limb-Threatening Ischemia ― Study Protocol for the HOTFOOT Multicenter Randomized Controlled Trial ―
title_fullStr Combined Treatment With Hyperbaric Oxygen Therapy and Endovascular Therapy for Patients With Chronic Limb-Threatening Ischemia ― Study Protocol for the HOTFOOT Multicenter Randomized Controlled Trial ―
title_full_unstemmed Combined Treatment With Hyperbaric Oxygen Therapy and Endovascular Therapy for Patients With Chronic Limb-Threatening Ischemia ― Study Protocol for the HOTFOOT Multicenter Randomized Controlled Trial ―
title_short Combined Treatment With Hyperbaric Oxygen Therapy and Endovascular Therapy for Patients With Chronic Limb-Threatening Ischemia ― Study Protocol for the HOTFOOT Multicenter Randomized Controlled Trial ―
title_sort combined treatment with hyperbaric oxygen therapy and endovascular therapy for patients with chronic limb-threatening ischemia ― study protocol for the hotfoot multicenter randomized controlled trial ―
topic Protocol Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8651475/
https://www.ncbi.nlm.nih.gov/pubmed/34950800
http://dx.doi.org/10.1253/circrep.CR-21-0097
work_keys_str_mv AT satoyusuke combinedtreatmentwithhyperbaricoxygentherapyandendovasculartherapyforpatientswithchroniclimbthreateningischemiastudyprotocolforthehotfootmulticenterrandomizedcontrolledtrial
AT urasawakazushi combinedtreatmentwithhyperbaricoxygentherapyandendovasculartherapyforpatientswithchroniclimbthreateningischemiastudyprotocolforthehotfootmulticenterrandomizedcontrolledtrial
AT morishitatetsuji combinedtreatmentwithhyperbaricoxygentherapyandendovasculartherapyforpatientswithchroniclimbthreateningischemiastudyprotocolforthehotfootmulticenterrandomizedcontrolledtrial
AT tanmichinao combinedtreatmentwithhyperbaricoxygentherapyandendovasculartherapyforpatientswithchroniclimbthreateningischemiastudyprotocolforthehotfootmulticenterrandomizedcontrolledtrial
AT hayakawanaoki combinedtreatmentwithhyperbaricoxygentherapyandendovasculartherapyforpatientswithchroniclimbthreateningischemiastudyprotocolforthehotfootmulticenterrandomizedcontrolledtrial
AT tokudatakahiro combinedtreatmentwithhyperbaricoxygentherapyandendovasculartherapyforpatientswithchroniclimbthreateningischemiastudyprotocolforthehotfootmulticenterrandomizedcontrolledtrial
AT nakanoakira combinedtreatmentwithhyperbaricoxygentherapyandendovasculartherapyforpatientswithchroniclimbthreateningischemiastudyprotocolforthehotfootmulticenterrandomizedcontrolledtrial
AT miyazawatsuyoshi combinedtreatmentwithhyperbaricoxygentherapyandendovasculartherapyforpatientswithchroniclimbthreateningischemiastudyprotocolforthehotfootmulticenterrandomizedcontrolledtrial
AT shimookayoshinori combinedtreatmentwithhyperbaricoxygentherapyandendovasculartherapyforpatientswithchroniclimbthreateningischemiastudyprotocolforthehotfootmulticenterrandomizedcontrolledtrial
AT minegishiyoshiki combinedtreatmentwithhyperbaricoxygentherapyandendovasculartherapyforpatientswithchroniclimbthreateningischemiastudyprotocolforthehotfootmulticenterrandomizedcontrolledtrial
AT dannourayutaka combinedtreatmentwithhyperbaricoxygentherapyandendovasculartherapyforpatientswithchroniclimbthreateningischemiastudyprotocolforthehotfootmulticenterrandomizedcontrolledtrial
AT ikedahiroyuki combinedtreatmentwithhyperbaricoxygentherapyandendovasculartherapyforpatientswithchroniclimbthreateningischemiastudyprotocolforthehotfootmulticenterrandomizedcontrolledtrial
AT hayashitaichi combinedtreatmentwithhyperbaricoxygentherapyandendovasculartherapyforpatientswithchroniclimbthreateningischemiastudyprotocolforthehotfootmulticenterrandomizedcontrolledtrial
AT miwatakashi combinedtreatmentwithhyperbaricoxygentherapyandendovasculartherapyforpatientswithchroniclimbthreateningischemiastudyprotocolforthehotfootmulticenterrandomizedcontrolledtrial
AT hiedashohei combinedtreatmentwithhyperbaricoxygentherapyandendovasculartherapyforpatientswithchroniclimbthreateningischemiastudyprotocolforthehotfootmulticenterrandomizedcontrolledtrial